Information PortalData Portal

Data Matrix

Tools & Workflows

Documentation

Renal Cell Carcinoma (Disease or Phenotype)

Description: A disease or phenotype in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Renal Cell Carcinoma's neighborhood in the knowledge graph.

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
	temsirolimus Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Renal Cell Carcinoma Disease or Phenotype (Entity type)
	Everolimus Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Renal Cell Carcinoma Disease or Phenotype (Entity type)
	Lenvatinib Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Renal Cell Carcinoma Disease or Phenotype (Entity type)
	Tivozanib Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Renal Cell Carcinoma Disease or Phenotype (Entity type)
	Sorafenib Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Renal Cell Carcinoma Disease or Phenotype (Entity type)
	AG-013736 Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Renal Cell Carcinoma Disease or Phenotype (Entity type)
	Sunitinib Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Renal Cell Carcinoma Disease or Phenotype (Entity type)
	1,18-Dihydroxy-12-[2-(4-hydroxy-3-methoxy-cyclohexyl)-1-methyl-ethyl]-19,30,33-trimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-aza-tricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone;Rapamycin Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Renal Cell Carcinoma Disease or Phenotype (Entity type)
	SID103905642 Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Renal Cell Carcinoma Disease or Phenotype (Entity type)
	Cabozantinib Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Renal Cell Carcinoma Disease or Phenotype (Entity type)

temsirolimus
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Renal Cell Carcinoma
Disease or Phenotype (Entity type)

Everolimus
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Renal Cell Carcinoma
Disease or Phenotype (Entity type)

Lenvatinib
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Renal Cell Carcinoma
Disease or Phenotype (Entity type)

Tivozanib
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Renal Cell Carcinoma
Disease or Phenotype (Entity type)

Sorafenib
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Renal Cell Carcinoma
Disease or Phenotype (Entity type)

AG-013736
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Renal Cell Carcinoma
Disease or Phenotype (Entity type)

Sunitinib
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Renal Cell Carcinoma
Disease or Phenotype (Entity type)

1,18-Dihydroxy-12-[2-(4-hydroxy-3-methoxy-cyclohexyl)-1-methyl-ethyl]-19,30,33-trimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-aza-tricyclo[30.3.1.0*4,9*]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone;Rapamycin
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Renal Cell Carcinoma
Disease or Phenotype (Entity type)

SID103905642
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Renal Cell Carcinoma
Disease or Phenotype (Entity type)

Cabozantinib
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Renal Cell Carcinoma
Disease or Phenotype (Entity type)

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025